China
· Delayed Price · Currency is CNY Guangzhou Wondfo Biotech Co.,Ltd Company Description
Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions in China.
The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases, inflammation, kidney injury, sex hormones, thyroid function, diabetes, tumor, and other diseases.
It also provides blood coagulation, optical coagulation, and dry chemistry analyzers, as well as automatic chemiluminescence immunoassay and molecular diagnostic analyzers.
Its products are used in clinical testing, critical illness, chronic disease management, primary care, epidemic monitoring, disaster relief, on-site law enforcement, and family personal health management.
The company sells its products to approximately 140 countries and regions worldwide. The company was founded in 1992 and is based in Guangzhou, China.
| Country | China |
| Founded | 1992 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 3,404 |
| CEO | Zhongxiong Peng |
Contact Details
Address: No.8 Lizhishan Road Guangzhou China | |
| Phone | 86 40 0830 8768 |
| Website | wondfo.com.cn |
Stock Details
| Ticker Symbol | 300482 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002102 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Zhongxiong Peng | GM and Director |
| Fang Xia Yu | Chief Financial Officer and Deputy GM |
| Yaping Zhao | Deputy General Manager and Non-Independent Director |
| Hong Hu | Board Secretary |
| Ke Ren Kang | Deputy General Manager |